Almoosa Health Company (TADAWUL:4018)

Saudi Arabia · Delayed Price · Currency is SAR

141.50

+0.10 (0.07%)

Mar 3, 2026, 3:14 PM AST

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Medical Services	825.55M	735.45M	661.45M	577.23M	519.65M
Medical Services Growth	12.25%	11.19%	14.59%	11.08%	-
Rehabilitation	118.54M	56.82M	-	-	-
Rehabilitation Growth	108.64%	-	-	-	-
Pharmaceuticals	258.24M	186.71M	154.59M	124.31M	109.32M
Pharmaceuticals Growth	38.31%	20.78%	24.36%	13.71%	-
Total	1.20B	978.97M	816.04M	701.54M	628.97M
Total Growth	22.82%	19.97%	16.32%	11.54%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Saudi Arabia	1.20B	978.97M	816.04M	701.54M	628.97M
Saudi Arabia Growth	22.82%	19.97%	16.32%	11.54%	-
Total	1.20B	978.97M	816.04M	701.54M	628.97M
Total Growth	22.82%	19.97%	16.32%	11.54%	-

Source: S&P Global Market Intelligence.